迈普医学(301033.SZ)：“可吸收再生氧化纤维素止血颗粒”于近期进入临床试验阶段
Medprin Regenerative Medical Technologies Medprin Regenerative Medical Technologies (SZ:301033) Ge Long Hui A P P·2025-09-16 11:29

Core Viewpoint - MaiPu Medical (301033.SZ) has announced that its R&D project "Absorbable Regenerative Oxidized Cellulose Hemostatic Granules" has officially entered the clinical trial phase [1] Group 1: Product Development - The product is intended for use in surgical procedures where traditional hemostatic methods, such as ligation, are ineffective or impractical [1] - It serves as an auxiliary hemostatic product to control bleeding from capillaries, veins, and small arteries [1]